Leaflet APO-GO 5mg / ml solution for infusion in single-dose pre-filled syringe

Product code:
W66227003
Quantity:
50
Indicated for:
Parkinson's disease
Route of administration:
infusion
Substance:
apomorphine (antiparkinsonian agent)
ATC
N04BC07 — Nervous system | Dopaminergic agents | Dopamine agonists

Precautions:

Driving impairment

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse

Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression

Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol

Avoid alcohol

Avoid alcohol during treatment.

Hypotension / fall risk

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning

Elderly warning

Older people may have an increased risk of side effects.

Withdrawal / do not stop abruptly

Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Apomorphine is a dopamine receptor agonist used in the treatment of Parkinson's disease, particularly for managing motor block episodes (off episodes). It works by directly stimulating dopamine receptors in the brain, alleviating motor symptoms such as rigidity, tremor, and bradykinesia.

Apomorphine is administered as subcutaneous injections or through continuous infusion pumps, depending on the patient's needs. It is often used as a rescue therapy for patients who do not respond adequately to oral treatments.

Common side effects include nausea, vomiting, orthostatic hypotension, and drowsiness. In rare cases, allergic reactions or compulsive behaviors may occur. It is important for treatment to be initiated under strict medical supervision.

Apomorphine is a valuable therapeutic option for patients with Parkinson's disease, helping to improve quality of life by reducing motor block episodes.

General data about APO-GO 5mg / ml

Substance:
apomorphine
Date of latest medicines list:
01-06-2026
Product code:
W66227003
Concentration:
5mg / ml
Pharmaceutical form:
solution for infusion in single-dose pre-filled syringe
Quantity:
50
Product type:
Original
Price:
4690.45 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ROVI CONTRACT MANUFACTURING, S.L. - SPANIA
Holder:
STADA ARZNEIMITTEL AG - GERMANIA
Number:
12115/2019/03
Shelf life:
2 years-after packing for marketing; after the first opening-it is used immediately

Concentrations available for apomorphine

  • 10mg/ml
  • 2mg
  • 3mg
  • 5mg/ml

Compensation lists for APO-GO 5mg / ml STADA

G12 (C1) - Parkinson's disease

Price
4690.45 RON
Copayment
4690.45 RON
Patient
0.00 RON